Cardiovascular Risk Factors, Diabetes, Hyperlipidemia, Hypertension, Obesity, Smoking
Conditions
Keywords
Cardiovascular risk management, Hyperlipidemia, Hypertension, Diabetes, Obesity
Brief summary
The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries. The patient's participation consists of a single study visit during a routine visit of the patient to the clinic/office. Study variables will be measured: * By an interview between physician and patient during the visit and/or available medical records' information: social and demographic patient characteristics, relevant family medical history, current medication. * By questions asked to the physician: physician perception of patients' CV risk factor, guidelines adherence and cost-containment. * By measurement performed to the patient during the visit: weight, height, BMI, waist and hip circumference will be measured. * CV risk factors (blood parameters) will be measured by collecting available data documented within the last year in the medical records and by the collection and analyses of a blood sample during the visit.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Provision of informed consent. * Patients 50+ years old, with at least one additional CV risk factor (with no previous CV event or hospitalisation for a CV event) from Primary Care or hospital outpatient clinic.
Exclusion criteria
* Subjects who are unwilling or unable to provide informed consent * Previous CV disease event or hospitalisation for a CV event * Current participation in a clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL-cholesterol, systolic and diastolic blood pressure, Tot. cholesterol, Non-HDL cholesterol, HDL-cholesterol, waist and hip circumference, HbA1c | Cross-sectional |
| Gender, age, patients with diabetes and/or hypertension (%), smoker status, family medical history. | Cross-sectional |
Secondary
| Measure | Time frame |
|---|---|
| BMI, Score based 10 year CHD mortality > 5%, High Risk patients (no. and %) | Cross-sectional |
| Use of concomitant medication: anticoagulant, anti hypertensive, antidiabetic, lipid-lowering drugs | Cross-sectional |
| Biomarkers: Apo-A1, Apo-B, Hs-CRP, Creatinine, albuminuria, uric acid, glomerular filtration rate. | Cross-sectional |
Countries
Austria, Belgium, France, Germany, Greece, Norway, Russia, Spain, Sweden, Switzerland, Turkey (Türkiye), United Kingdom
Outcome results
None listed